The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Brain Tumor Diagnosis and Therapeutics-Global Market Insights and Sales Trends 2025
Synopsis
Brain tumors are treated with surgery, radiation therapy and chemotherapy. This report mainly focuses on brain tumor diagnosis and therapeutics market.
The global Brain Tumor Diagnosis and Therapeutics market size is expected to reach US$ 4685.7 million by 2029, growing at a CAGR of 9.8% from 2023 to 2029. The market is mainly driven by the significant applications of Brain Tumor Diagnosis and Therapeutics in various end use industries. The expanding demands from the Surgery, Radiation Therapy, Chemotherapy and Immunotherapy, are propelling Brain Tumor Diagnosis and Therapeutics market. MRI, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the CT Scan segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Brain Tumor Diagnosis and Therapeutics market, driven by demand from China, the second largest economy with some signs of stabilising, the Brain Tumor Diagnosis and Therapeutics market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Brain Tumor Diagnosis and Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Brain Tumor Diagnosis and Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Brain Tumor Diagnosis and Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Brain Tumor Diagnosis and Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Brain Tumor Diagnosis and Therapeutics covered in this report include GE Healthcare, Hitachi, Philips Healthcare, Siemens Healthineers, Toshiba Corporation, Fujifilm Corporation, Shimadzu Corporation, Merck & Co. and AstraZeneca, etc.
The global Brain Tumor Diagnosis and Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GE Healthcare
Hitachi
Philips Healthcare
Siemens Healthineers
Toshiba Corporation
Fujifilm Corporation
Shimadzu Corporation
Merck & Co.
AstraZeneca
Bristol Myer Squibb
Novartis
Roche Diagnostics
Global Brain Tumor Diagnosis and Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Brain Tumor Diagnosis and Therapeutics market, Segment by Type:
MRI
CT Scan
Tissue Sampling
PET-CT Scan
Cerebral Arteriogram
Lumbar Puncture
Molecular Testing
EEG
Global Brain Tumor Diagnosis and Therapeutics market, by Application
Surgery
Radiation Therapy
Chemotherapy
Immunotherapy
Targeted Therapy
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Brain Tumor Diagnosis and Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Brain tumors are treated with surgery, radiation therapy and chemotherapy. This report mainly focuses on brain tumor diagnosis and therapeutics market.
The global Brain Tumor Diagnosis and Therapeutics market size is expected to reach US$ 4685.7 million by 2029, growing at a CAGR of 9.8% from 2023 to 2029. The market is mainly driven by the significant applications of Brain Tumor Diagnosis and Therapeutics in various end use industries. The expanding demands from the Surgery, Radiation Therapy, Chemotherapy and Immunotherapy, are propelling Brain Tumor Diagnosis and Therapeutics market. MRI, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the CT Scan segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Brain Tumor Diagnosis and Therapeutics market, driven by demand from China, the second largest economy with some signs of stabilising, the Brain Tumor Diagnosis and Therapeutics market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Brain Tumor Diagnosis and Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Brain Tumor Diagnosis and Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Brain Tumor Diagnosis and Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Brain Tumor Diagnosis and Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Brain Tumor Diagnosis and Therapeutics covered in this report include GE Healthcare, Hitachi, Philips Healthcare, Siemens Healthineers, Toshiba Corporation, Fujifilm Corporation, Shimadzu Corporation, Merck & Co. and AstraZeneca, etc.
The global Brain Tumor Diagnosis and Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GE Healthcare
Hitachi
Philips Healthcare
Siemens Healthineers
Toshiba Corporation
Fujifilm Corporation
Shimadzu Corporation
Merck & Co.
AstraZeneca
Bristol Myer Squibb
Novartis
Roche Diagnostics
Global Brain Tumor Diagnosis and Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Brain Tumor Diagnosis and Therapeutics market, Segment by Type:
MRI
CT Scan
Tissue Sampling
PET-CT Scan
Cerebral Arteriogram
Lumbar Puncture
Molecular Testing
EEG
Global Brain Tumor Diagnosis and Therapeutics market, by Application
Surgery
Radiation Therapy
Chemotherapy
Immunotherapy
Targeted Therapy
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Brain Tumor Diagnosis and Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Brain Tumor Diagnosis and Therapeutics
1.1 Brain Tumor Diagnosis and Therapeutics Market Overview
1.1.1 Brain Tumor Diagnosis and Therapeutics Product Scope
1.1.2 Brain Tumor Diagnosis and Therapeutics Market Status and Outlook
1.2 Global Brain Tumor Diagnosis and Therapeutics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Brain Tumor Diagnosis and Therapeutics Market Size by Region (2018-2029)
1.4 Global Brain Tumor Diagnosis and Therapeutics Historic Market Size by Region (2018-2023)
1.5 Global Brain Tumor Diagnosis and Therapeutics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Brain Tumor Diagnosis and Therapeutics Market Size (2018-2029)
1.6.1 North America Brain Tumor Diagnosis and Therapeutics Market Size (2018-2029)
1.6.2 Europe Brain Tumor Diagnosis and Therapeutics Market Size (2018-2029)
1.6.3 Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Size (2018-2029)
1.6.4 Latin America Brain Tumor Diagnosis and Therapeutics Market Size (2018-2029)
1.6.5 Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size (2018-2029)
2 Brain Tumor Diagnosis and Therapeutics Market by Type
2.1 Introduction
2.1.1 MRI
2.1.2 CT Scan
2.1.3 Tissue Sampling
2.1.4 PET-CT Scan
2.1.5 Cerebral Arteriogram
2.1.6 Lumbar Puncture
2.1.7 Molecular Testing
2.1.8 EEG
2.2 Global Brain Tumor Diagnosis and Therapeutics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Brain Tumor Diagnosis and Therapeutics Historic Market Size by Type (2018-2023)
2.2.2 Global Brain Tumor Diagnosis and Therapeutics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Brain Tumor Diagnosis and Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Brain Tumor Diagnosis and Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Brain Tumor Diagnosis and Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Brain Tumor Diagnosis and Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Brain Tumor Diagnosis and Therapeutics Revenue Breakdown by Type (2018-2029)
3 Brain Tumor Diagnosis and Therapeutics Market Overview by Application
3.1 Introduction
3.1.1 Surgery
3.1.2 Radiation Therapy
3.1.3 Chemotherapy
3.1.4 Immunotherapy
3.1.5 Targeted Therapy
3.2 Global Brain Tumor Diagnosis and Therapeutics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Brain Tumor Diagnosis and Therapeutics Historic Market Size by Application (2018-2023)
3.2.2 Global Brain Tumor Diagnosis and Therapeutics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Brain Tumor Diagnosis and Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Brain Tumor Diagnosis and Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Brain Tumor Diagnosis and Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Brain Tumor Diagnosis and Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Brain Tumor Diagnosis and Therapeutics Revenue Breakdown by Application (2018-2029)
4 Brain Tumor Diagnosis and Therapeutics Competition Analysis by Players
4.1 Global Brain Tumor Diagnosis and Therapeutics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Brain Tumor Diagnosis and Therapeutics as of 2022)
4.3 Date of Key Players Enter into Brain Tumor Diagnosis and Therapeutics Market
4.4 Global Top Players Brain Tumor Diagnosis and Therapeutics Headquarters and Area Served
4.5 Key Players Brain Tumor Diagnosis and Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Brain Tumor Diagnosis and Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 GE Healthcare
5.1.1 GE Healthcare Profile
5.1.2 GE Healthcare Main Business
5.1.3 GE Healthcare Brain Tumor Diagnosis and Therapeutics Products, Services and Solutions
5.1.4 GE Healthcare Brain Tumor Diagnosis and Therapeutics Revenue (US$ Million) & (2018-2023)
5.1.5 GE Healthcare Recent Developments
5.2 Hitachi
5.2.1 Hitachi Profile
5.2.2 Hitachi Main Business
5.2.3 Hitachi Brain Tumor Diagnosis and Therapeutics Products, Services and Solutions
5.2.4 Hitachi Brain Tumor Diagnosis and Therapeutics Revenue (US$ Million) & (2018-2023)
5.2.5 Hitachi Recent Developments
5.3 Philips Healthcare
5.3.1 Philips Healthcare Profile
5.3.2 Philips Healthcare Main Business
5.3.3 Philips Healthcare Brain Tumor Diagnosis and Therapeutics Products, Services and Solutions
5.3.4 Philips Healthcare Brain Tumor Diagnosis and Therapeutics Revenue (US$ Million) & (2018-2023)
5.3.5 Siemens Healthineers Recent Developments
5.4 Siemens Healthineers
5.4.1 Siemens Healthineers Profile
5.4.2 Siemens Healthineers Main Business
5.4.3 Siemens Healthineers Brain Tumor Diagnosis and Therapeutics Products, Services and Solutions
5.4.4 Siemens Healthineers Brain Tumor Diagnosis and Therapeutics Revenue (US$ Million) & (2018-2023)
5.4.5 Siemens Healthineers Recent Developments
5.5 Toshiba Corporation
5.5.1 Toshiba Corporation Profile
5.5.2 Toshiba Corporation Main Business
5.5.3 Toshiba Corporation Brain Tumor Diagnosis and Therapeutics Products, Services and Solutions
5.5.4 Toshiba Corporation Brain Tumor Diagnosis and Therapeutics Revenue (US$ Million) & (2018-2023)
5.5.5 Toshiba Corporation Recent Developments
5.6 Fujifilm Corporation
5.6.1 Fujifilm Corporation Profile
5.6.2 Fujifilm Corporation Main Business
5.6.3 Fujifilm Corporation Brain Tumor Diagnosis and Therapeutics Products, Services and Solutions
5.6.4 Fujifilm Corporation Brain Tumor Diagnosis and Therapeutics Revenue (US$ Million) & (2018-2023)
5.6.5 Fujifilm Corporation Recent Developments
5.7 Shimadzu Corporation
5.7.1 Shimadzu Corporation Profile
5.7.2 Shimadzu Corporation Main Business
5.7.3 Shimadzu Corporation Brain Tumor Diagnosis and Therapeutics Products, Services and Solutions
5.7.4 Shimadzu Corporation Brain Tumor Diagnosis and Therapeutics Revenue (US$ Million) & (2018-2023)
5.7.5 Shimadzu Corporation Recent Developments
5.8 Merck & Co.
5.8.1 Merck & Co. Profile
5.8.2 Merck & Co. Main Business
5.8.3 Merck & Co. Brain Tumor Diagnosis and Therapeutics Products, Services and Solutions
5.8.4 Merck & Co. Brain Tumor Diagnosis and Therapeutics Revenue (US$ Million) & (2018-2023)
5.8.5 Merck & Co. Recent Developments
5.9 AstraZeneca
5.9.1 AstraZeneca Profile
5.9.2 AstraZeneca Main Business
5.9.3 AstraZeneca Brain Tumor Diagnosis and Therapeutics Products, Services and Solutions
5.9.4 AstraZeneca Brain Tumor Diagnosis and Therapeutics Revenue (US$ Million) & (2018-2023)
5.9.5 AstraZeneca Recent Developments
5.10 Bristol Myer Squibb
5.10.1 Bristol Myer Squibb Profile
5.10.2 Bristol Myer Squibb Main Business
5.10.3 Bristol Myer Squibb Brain Tumor Diagnosis and Therapeutics Products, Services and Solutions
5.10.4 Bristol Myer Squibb Brain Tumor Diagnosis and Therapeutics Revenue (US$ Million) & (2018-2023)
5.10.5 Bristol Myer Squibb Recent Developments
5.11 Novartis
5.11.1 Novartis Profile
5.11.2 Novartis Main Business
5.11.3 Novartis Brain Tumor Diagnosis and Therapeutics Products, Services and Solutions
5.11.4 Novartis Brain Tumor Diagnosis and Therapeutics Revenue (US$ Million) & (2018-2023)
5.11.5 Novartis Recent Developments
5.12 Roche Diagnostics
5.12.1 Roche Diagnostics Profile
5.12.2 Roche Diagnostics Main Business
5.12.3 Roche Diagnostics Brain Tumor Diagnosis and Therapeutics Products, Services and Solutions
5.12.4 Roche Diagnostics Brain Tumor Diagnosis and Therapeutics Revenue (US$ Million) & (2018-2023)
5.12.5 Roche Diagnostics Recent Developments
6 North America
6.1 North America Brain Tumor Diagnosis and Therapeutics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Brain Tumor Diagnosis and Therapeutics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Brain Tumor Diagnosis and Therapeutics Market Dynamics
11.1 Brain Tumor Diagnosis and Therapeutics Industry Trends
11.2 Brain Tumor Diagnosis and Therapeutics Market Drivers
11.3 Brain Tumor Diagnosis and Therapeutics Market Challenges
11.4 Brain Tumor Diagnosis and Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
